feed,title,long_url,short_url
MedRxiv,Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 1 immunoglobulins: a phase I/II dose finding study,https://medrxiv.org/cgi/content/short/2023.03.07.23286893v1?rss=1,https://da.gd/gLjnG
